Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$34.01 USD
-1.15 (-3.27%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $33.98 -0.03 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
LEGN 34.01 -1.15(-3.27%)
Will LEGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LEGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LEGN
Company News for Aug 12, 2025
Key Inflation Data in Focus
LEGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
What Makes Legend Biotech (LEGN) a New Buy Stock
Other News for LEGN
Is LEGN lining up for a decline? Fell Below 20 Day Moving Average shows up after declining 3.27%
Is LEGN building bullish momentum? Crossed Above 20 Day Moving Average shows up after rising 2.0%
20 Day Moving Average Resistance appears for LEGN after 0.38% move
Is LEGN preparing to trend higher? MACD Bullish Signal Line Cross shows up after advancing 1.36%
Stochastic Buy Signal appears for LEGN after 2.33% move